These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16094732)

  • 21. Communicable Diseases Report, NSW: June 2003.
    NSW Infection Control Resource Centre
    N S W Public Health Bull; 2003 Jun; 14(6):124-5, 128-9. PubMed ID: 12908006
    [No Abstract]   [Full Text] [Related]  

  • 22. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunization update for primary health care providers.
    Osguthorpe NC; Morgan EP
    Nurse Pract; 1995 Jun; 20(6):52-4, 64-5. PubMed ID: 7659320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.
    McLean AR
    Proc Biol Sci; 1995 Sep; 261(1362):389-93. PubMed ID: 8587880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011.
    Pediatr Infect Dis J; 2011 Jul; 30(7):606-7. PubMed ID: 21673549
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunizations. Bases for the establishment of a vaccination schedule for children].
    Jeune M
    Rev Venez Sanid Asist Soc; 1965 Dec; 30(4):499-507. PubMed ID: 5879025
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
    Andrus JK; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
    [No Abstract]   [Full Text] [Related]  

  • 28. Q&A--Economic analyses for vaccine introduction decisions in low- and middle- income countries.
    Hutubessy R
    BMC Med; 2013 Mar; 11():71. PubMed ID: 23496946
    [No Abstract]   [Full Text] [Related]  

  • 29. Expanding access to non-traditional vaccines: a perspective from Indonesia.
    Suwantika AA; Postma MJ
    Expert Rev Vaccines; 2014 Dec; 13(12):1419-21. PubMed ID: 25147940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against vaccine-preventable diseases in medical students: a follow up.
    Urwyler P; Dierig A; Walther K; Heininger U
    Pediatr Infect Dis J; 2014 Oct; 33(10):1057-9. PubMed ID: 24776519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of current and potential use of information and communication technologies for immunization promotion among adolescents.
    Amicizia D; Domnich A; Gasparini R; Bragazzi NL; Lai PL; Panatto D
    Hum Vaccin Immunother; 2013 Dec; 9(12):2634-42. PubMed ID: 23954845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines for the developing world: current status and future directions.
    Wenger J
    Vaccine; 2001 Feb; 19(13-14):1588-91. PubMed ID: 11166879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The national immunization program of The Netherlands.
    Verbrugge HP
    Pediatrics; 1990 Dec; 86(6 Pt 2):1060-3. PubMed ID: 2243740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International childhood vaccine initiative.
    Robbins A; Freeman P; Powell KR
    Pediatr Infect Dis J; 1993 Jun; 12(6):523-7. PubMed ID: 8345984
    [No Abstract]   [Full Text] [Related]  

  • 35. [Infectious diseases in Poland in 1991].
    Magdzik W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1993; 47(1-2):55-60. PubMed ID: 8351388
    [No Abstract]   [Full Text] [Related]  

  • 36. The many shades of vaccine hesitancy.
    Burki T
    Lancet Infect Dis; 2015 Oct; 15(10):1138-1139. PubMed ID: 26461949
    [No Abstract]   [Full Text] [Related]  

  • 37. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies R
    Commun Dis Intell Q Rep; 2013 Jun; 37(2):E130-4. PubMed ID: 24168086
    [No Abstract]   [Full Text] [Related]  

  • 38. Communicable diseases report, New South Wales, for July and August 2005.
    N S W Public Health Bull; 2005; 16(9-10):169-73. PubMed ID: 16596154
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccines for children in rich and poor countries.
    Shann F; Steinhoff MC
    Lancet; 1999 Sep; 354 Suppl 2():SII7-11. PubMed ID: 10507252
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral vaccines: new needs, new possibilities.
    Aziz MA; Midha S; Waheed SM; Bhatnagar R
    Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.